These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28762762)

  • 21. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
    Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
    J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction.
    Kempf T; Björklund E; Olofsson S; Lindahl B; Allhoff T; Peter T; Tongers J; Wollert KC; Wallentin L
    Eur Heart J; 2007 Dec; 28(23):2858-65. PubMed ID: 17977844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
    Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
    Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers.
    Eggers KM; Lindhagen L; Lindhagen L; Baron T; Erlinge D; Hjort M; Jernberg T; Marko-Varga G; Rezeli M; Spaak J; Lindahl B
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):806-812. PubMed ID: 34100060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
    Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convalescent Growth Differentiation Factor-15 and Long-Term Outcomes after an Acute Coronary Syndrome.
    Greer CE; Chew-Harris J; Adamson PD; Pemberton CJ; Pickering JW; Pilbrow AP; Frampton CM; Troughton RW; Doughty RN; Richards AM
    J Appl Lab Med; 2024 Jul; 9(4):672-683. PubMed ID: 38635817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
    Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Yusuf S; Siegbahn A; Wallentin L
    Am Heart J; 2017 Aug; 190():94-103. PubMed ID: 28760218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
    Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in patients with minor troponin-I elevation but without acute myocardial infarction.
    Lee SH; Yoon SB; Jung JH; Choi SH; Lee N; Cho GY; Oh DJ; Rhim CY; Lee KH
    Coron Artery Dis; 2006 May; 17(3):249-53. PubMed ID: 16728875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Yang J
    Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction.
    Walter J; Nestelberger T; Boeddinghaus J; Twerenbold R; Croton L; Badertscher P; Wildi K; Wussler D; du Fay de Lavallaz J; Mueller C;
    Int J Cardiol; 2019 Oct; 292():241-245. PubMed ID: 31174919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction--contribution of cystatin C assessment.
    Derzhko R; Plaksej R; Przewlocka-Kosmala M; Kosmala W
    Coron Artery Dis; 2009 Nov; 20(7):453-61. PubMed ID: 19741512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uric acid and mild renal impairment in patients with ST-elevation myocardial infarction.
    Lazzeri C; Valente S; Chiostri M; Spini V; Angelotti P; Gensini GF
    Scand Cardiovasc J; 2015 Feb; 49(1):14-9. PubMed ID: 25659042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.